Vaccine prompts HIV antibodies in 97 per cent of people in small study

Norge Nyheter Nyheter

Vaccine prompts HIV antibodies in 97 per cent of people in small study
Norge Siste Nytt,Norge Overskrifter
  • 📰 newscientist
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 51%

An experimental HIV vaccine led to antibodies against the virus in 35 out of 36 volunteers, but whether this offers protection against the infection is unclear

As a result, many groups of researchers are seeking to develop vaccines that stimulate a type of immune cell called B-cells to generate so-called broadly neutralising antibodies. These work against parts of the HIV virus that vary little between strains.

When it comes to HIV, incorporating viral proteins into a vaccine may activate this subset of B-cells.at the University of Washington in Seattle and her colleagues recruited 48 volunteers without HIV to test a vaccine that stimulates B-cells to make HIV-specific broadly neutralising antibodies, based on laboratory and animal studies.

After the injections, all the participants regularly provided blood samples for 16 weeks. Of those who received either the low or high vaccine doses, 97 per cent had HIV-specific broadly neutralising antibodies at the end of the study. Antibody levels were similar across the participants who received either the high or low vaccine doses, but marginally higher among those who had the high doses.

Across all the participants, including those given the saline solution, 98 per cent experienced mild side effects, such as fatigue, headaches and tenderness at the site of injection.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

newscientist /  🏆 541. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

HIV vaccine candidate induces immune response in early clinical trial: 'An important step forward' | CNNHIV vaccine candidate induces immune response in early clinical trial: 'An important step forward' | CNNAn experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune responses against the human immunodeficiency virus.
Les mer »

HIV vaccine candidate shows early promiseHIV vaccine candidate shows early promiseThe vaccine, called eOD-GT8 60mer, had a “favorable safety profile” and induced broadly neutralizing antibodies in 97%, or all but one, of the 36 recipients, according to the researcher…
Les mer »

GOP senators demand vote on military vaccine mandate in exchange for advancing NDAAGOP senators demand vote on military vaccine mandate in exchange for advancing NDAARepublicans say their party leaders should stand up to Democrats on key issues like vaccine mandates for military members.
Les mer »

Arizona researchers part of effort to create a Valley fever vaccineArizona researchers part of effort to create a Valley fever vaccineValley fever symptoms may become noticeable one to three weeks after a person inhales spores, the Centers for Disease Control and Prevention says.
Les mer »



Render Time: 2025-03-07 03:03:24